We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

External Cephalic Version Lacks Adverse Outcomes

By HospiMedica International staff writers
Posted on 10 Aug 2018
Print article
Image: New research suggests ECV reduces the need for Cesarean delivery (Photo courtesy of Berlin Charité).
Image: New research suggests ECV reduces the need for Cesarean delivery (Photo courtesy of Berlin Charité).
Efforts to reposition a fetus in the breech position via external cephalic version (ECV) significantly improve the likelihood of a vaginal delivery, according to a new study.

Researchers at Northwestern University (NU; Chicago, IL, USA) conducted a retrospective cohort study of 4,117 women with singleton gestations in non-vertex presentation that delivered during a 10-year period (2006 to 2016). Women undergoing an ECV attempt at 37 weeks of gestation or greater were compared with those with non-vertex fetuses who did not undergo an ECV attempt. The primary outcome was a composite of perinatal morbidity and mortality. Secondary outcomes included neonatal intensive care unit (NICU) admission and neonatal anemia.

ECV was attempted in only about a third (30.7%) of the women, with 40.3% of the attempts resulting in successful repositioning of the fetus. For both the primary and secondary outcomes, there were no significant differences between those who did and did not receive an attempted ECV. The full composite of the primary outcome included stillbirth, neonatal death within 72 hours, Apgar score less than five at five minutes, umbilical artery pH less than 7.0, base deficit 12 mmol/L or greater, or neonatal therapeutic hypothermia.

Analysis revealed that among women who underwent attempted ECV, more were non-Hispanic white, multiparous, and had a lower mean body mass index (BMI) at time of delivery compared with those who did not have an ECV attempt. Importantly, among the 40% of women who had successful ECV, as many as 79% delivered vaginally, whereas among those who did not undergo an ECV attempt and continued to have non-vertex fetal presentation at time of delivery, fewer than one percent ultimately delivered vaginally. The study was published in the August 2018 issue of Obstetrics & Gynecology.

“An ECV attempt at term is not associated with increased perinatal morbidity or mortality, compared with expectant management. Although success can be difficult to predict reliably, an ECV attempt does result in a significantly reduced chance of cesarean delivery,” concluded lead author Moeun Son, MD, and colleagues. “As such, these data support the existing recommendations that an ECV attempt should be encouraged when fetal malpresentation exists at term.”

ECV is a manual procedure by which an attempt is made to turn a breech baby from a buttocks- or foot-first position to a head-first position in order to enable vaginal delivery. It is usually performed after about 37 gestational weeks, as breech presentation greatly decreases after that. To perform ECV, both hands are placed on the mother's abdomen around the baby, who is then moved up and away from the pelvis and gently turned in several steps from breech, to a sideways position, and finally to a head first presentation.

Related Links:
Northwestern University

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
24.5-inch Full HD 2D OLED Medical Monitor
PVM-2551MD

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Surgical Techniques

view channel
Image: NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence (Photo courtesy of NICO Corporation)

Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors

Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more